COC(=O)[C@]1(S(=O)(=O)c2ccccc2)C[C@@H]2ON=C(c3ccc(OC)cc3)[C@@H]2C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?